Bayer and Evogene Sign Deal to Improve Wheat

Bayer CropScience and Evogene (Rehovot, Israel), an agchems firm, have signed a five-year agreement to collaborate on the development of novel species of wheat using both advanced breeding and genetic modification techniques. The focus of the R&D will be on optimizing wheat’s yield, drought tolerance and requirements for fertilizer use, as well as the enhancement of other traits, Bayer says.   Bayer will pay Evogene approximately $20 million in upfront fees and annual research payments over the term of the agreement. Evogene also will receive...

This information is only available to Chemical Week subscribers.

Forgot your user ID or password?
Click here to have it sent to you.

Email Address First Name Last Name

Not an IHS Chemical Week 24/7 member yet? Here's why you should be: Searchable online archive access of the last 2 years of Chemical Week. Print or digital magazine subscription Price and market change alerts Economic data and statistics Buyers' Guides Webcasts | whitepapers